Loading…
Lobbying Spend
—
Filings
66
Firms Hired
1
Active Period
2010–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act). Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act. Implementation of the Inflation Reduction Act. Education around NIH funding Issues around drug pricing.
Client expense: — · Firm income: $40,000
Matched citations: H.R.946
Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act). Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act. Implementation of the Inflation Reduction Act. Education around NIH funding Issues around drug pricing.
Client expense: — · Firm income: $40,000
Matched citations: H.R.946
Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act). Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act. Implementation of the Inflation Reduction Act. Education around NIH funding Issues around drug pricing.
Client expense: — · Firm income: $40,000
Matched citations: H.R.946
Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act). Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act. Implementation of the Inflation Reduction Act. Education around NIH funding.
Client expense: — · Firm income: $40,000
Matched citations: H.R.946
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute on Drug Abuse for fiscal year 2024.
2025 · second_quarter · Firm: W STRATEGIES, LLC
H.R.1990- American Innovation and R&D Competitiveness Act of 2023.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1990
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: W STRATEGIES, LLC
Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act). H.R.1 - One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act. Implementation of the Inflation Reduction Act. H.R.1492 - EPIC Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2025 · second_quarter · Firm: W STRATEGIES, LLC
Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act). H.R.1 - One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act. Implementation of the Inflation Reduction Act. H.R.1492 - EPIC Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1492
Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act). H.R.1 - One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act. Implementation of the Inflation Reduction Act. H.R.1492 - EPIC Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.946
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute on Drug Abuse for fiscal year 2024.
2025 · first_quarter · Firm: W STRATEGIES, LLC
H.R.1990- American Innovation and R&D Competitiveness Act of 2023.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1990
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2025 · first_quarter · Firm: W STRATEGIES, LLC
Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act). H.R.946 - ORPHAN Cures Act. Implementation of the Inflation Reduction Act. H.R.1492 - EPIC Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1492
Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act). H.R.946 - ORPHAN Cures Act. Implementation of the Inflation Reduction Act. H.R.1492 - EPIC Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.946
H.R.830 - HELP Copays Act. Legislation to reform PBMs. H.R.10545 - American Relief Act, 2025 as it relates to PBM reform.
Client expense: — · Firm income: $40,000
Matched citations: H.R.10545
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · fourth_quarter · Firm: W STRATEGIES, LLC
CMS rule on Medicare Coverage for Innovative Technology and H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1691
American Innovation and R&D Competitiveness Act of 2023
2024 · fourth_quarter · Firm: W STRATEGIES, LLC
H.R.2673 - American Innovation and R&D Competitiveness Act of 2023.
Client expense: — · Firm income: $40,000
Matched citations: H.R.2673
H.R.830 - HELP Copays Act. Legislation to reform PBMs. H.R.10545 - American Relief Act, 2025 as it relates to PBM reform.
Client expense: — · Firm income: $40,000
Matched citations: H.R.830
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · third_quarter · Firm: W STRATEGIES, LLC
CMS rule on Medicare Coverage for Innovative Technology and H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1691
American Innovation and R&D Competitiveness Act of 2023
2024 · third_quarter · Firm: W STRATEGIES, LLC
H.R.2673 - American Innovation and R&D Competitiveness Act of 2023.
Client expense: — · Firm income: $40,000
Matched citations: H.R.2673
H.R.830 - HELP Copays Act. Legislation to reform PBMs.
Client expense: — · Firm income: $40,000
Matched citations: H.R.830
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · second_quarter · Firm: W STRATEGIES, LLC
CMS rule on Medicare Coverage for Innovative Technology and H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Implementation of Inflation Reduction Act of 2022.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1691
American Innovation and R&D Competitiveness Act of 2023
2024 · second_quarter · Firm: W STRATEGIES, LLC
H.R.2673 - American Innovation and R&D Competitiveness Act of 2023.
Client expense: — · Firm income: $40,000
Matched citations: H.R.2673
H.R.830 - HELP Copays Act. Legislation to reform PBMs.
Client expense: — · Firm income: $40,000
Matched citations: H.R.830
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · first_quarter · Firm: W STRATEGIES, LLC
CMS rule on Medicare Coverage for Innovative Technology and H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Implementation of Inflation Reduction Act of 2022.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1691
American Innovation and R&D Competitiveness Act of 2023
2024 · first_quarter · Firm: W STRATEGIES, LLC
H.R.2673 - American Innovation and R&D Competitiveness Act of 2023.
Client expense: — · Firm income: $40,000
Matched citations: H.R.2673
H.R.830 - HELP Copays Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.830
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2023 · fourth_quarter · Firm: W STRATEGIES, LLC
CMS rule on Medicare Coverage for Innovative Technology and H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Implementation of Inflation Reduction Act of 2022.
Client expense: — · Firm income: $40,000
Matched citations: H.R.1691
Source: Senate LDA